Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

PHASE2TerminatedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

Lonidamine

Trial Locations (34)

10016

New York University School of Medicine, New York

10021

Weill Medical College of Cornell University, New York

11530

Accumed Research Associates, Garden City

16801

State College Urologic Associates, State College

17604

Urological Associates of Lancaster, Lancaster

20770

Werner, Murdock & Francis, PA, Urology Associates, Greenbelt

29651

Radiant Research, Greer, Greer

33180

South Florida Medical Research, Aventura

33761

Tampa Bay Medical Research, Clearwater

34474

Florida Healthcare Research, Ocala

43212

Radiant Research. Columbus, Columbus

46825

Northeast Indiana research, LLC, Fort Wayne

47130

Metropolitan Urology, Jeffersonville

60640

Midwest Prostate & Urology Health Center, Chicago

61614

Specialty Care Research, Peoria

75390

UT Southwestern Medical Center at Dallas, Dept of Urology, Dallas

77024

Accelovance, Houston

77030

Baylor College of Medicine, Scott Department of Urology, Houston

78229

Urology San Antonio Research, San Antonio

80012

Urology Research Options, Aurora

85712

Advanced Clinical Therapeutics, Tucson

89109

Sheldon J. Freedman, MD Ltd., Las Vegas

90232

Urological Sciences Research Foundation, Culver City

90806

Atlantic Urological Medical Group, Long Beach

92103

San Diego Uro-Research, San Diego

92660

California Professional Research, Newport Beach

94027

Chris B. Threatt, MD Inc., Atherton

94305

Stanford University Hospital, Stanford

98043

Integrity Medical Research, LLC, Mountlake Terrace

06708

Connecticut Clinical Research Center Urology Specialists, Waterbury

08003

Delaware Valley Clinical Research, Cherry Hill

08648

Lawrenceville Urology, Lawrenceville

08060

Urology Healthcare Associates, Woodlane

02904

University Urological Research Institute, Providence

Sponsors
All Listed Sponsors
lead

Threshold Pharmaceuticals

INDUSTRY